Delivery Order SPE2DB22D2006-SPE2DB25FW3FK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Progesterone 200 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $7,627.49, represents a non-competitive set-aside award and is scheduled for completion by August 6, 2025. The pharmaceutical product will be delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Department's...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units, with a ceiling value of $8,677.17 and a firm fixed price structure. This non-set-aside award is classified as a delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $25,285.45. This firm fixed-price delivery order, which carries an ultimate completion date of July 29, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed price contract valued at $13,107.92. The delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, non-set-aside procurement. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.30 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a $27,245.19 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order, with performance to be executed at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $3,439.80. This non-set-aside delivery order will be completed by August 5, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Progesterone 100 mg capsules in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,001.13 and is scheduled for completion by July 30, 2025. The contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with the federal...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3FKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Progesterone 200 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $12,032.88, represents a non-competitive set-aside delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. This delivery order falls under the company's broader pharmaceutical supply mission for military and federal healthcare systems. This delivery order is a child contract executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, AmerisourceBergen supplies a wide range of medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare operations. The progesterone capsules serve as a hormone treatment product within the company's extensive portfolio of brand-name and generic pharmaceuticals distributed through its global pharmaceutical support vehicle to military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 8/7/25 |